Skip to main content
Article

Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?

Journal of Neuroimmune Pharmacology
DOI: 10.1007/s11481-019-09881-y
2Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Toghi, M., & Bitarafan, S. (2019, December 1). Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe? Journal of Neuroimmune Pharmacology. Springer. https://doi.org/10.1007/s11481-019-09881-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free